Zhejiang Huahai Pharmaceutical Co., Ltd. logo

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

Market Closed
10 Aug, 06:57
SSE SSE
¥
18. 19
+0.64
+3.6467%
¥
21.88B Market Cap
- P/E Ratio
0.8% Div Yield
79.01M Volume
- Eps
¥ 17.55
Previous Close
Add Transaction
Day Range
17.73 18.37
Year Range
13.73 27.97
Want to track 600521 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600521 closed today higher at ¥18.19, an increase of 3.6467% from yesterday's close, completing a monthly increase of 25.9695% or ¥3.75. Over the past 12 months, 600521 stock gained 7%.
600521 pays dividends to its shareholders, with the most recent payment made on Jun 18, 2026. The next estimated payment will be in In 10 months on Jun 18, 2027 for a total of ¥0.1.
The last earnings report, released on Apr 30, 2026, exceeded the consensus estimates by 0.05%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
Zhejiang Huahai Pharmaceutical Co., Ltd. has completed 11 stock splits, with the recent split occurring on Jun 08, 2020.
The company's stock is traded on one exchange.

600521 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.48
+0.2871%
Seres Group Co., Ltd.
¥ 56.03
-1.3904%
Great Wall Motor Co., Ltd.
¥ 15.69
+0.706%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.59
+2.148%
China Tourism Group Duty Free Corporation Limited
¥ 56.24
+0.7524%

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) FAQ

What is the stock price today?

The current price is ¥18.19.

On which exchange is it traded?

Zhejiang Huahai Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600521.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 21.88B.

Has Zhejiang Huahai Pharmaceutical Co., Ltd. ever had a stock split?

Zhejiang Huahai Pharmaceutical Co., Ltd. had 11 splits and the recent split was on Jun 08, 2020.

Zhejiang Huahai Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Bao Hua Chen CEO
SSE Exchange
CNE000001DL5 ISIN
CN Country
8,221 Employees
18 Jun 2026 Last Dividend
25 May 2018 Last Split
17 Feb 2003 IPO Date

Overview

Zhejiang Huahai Pharmaceutical Co., Ltd. is an established pharmaceutical company rooted in China with a global outreach. Founded in 1989, and having its headquarters in Linhai, China, the company has grown to become a significant player in the pharmaceutical industry both domestically and internationally. Zhejiang Huahai Pharmaceutical specializes in the research, development, production, and sale of a wide range of pharmaceutical products, offering solutions spanning various medical fields. Additionally, the company extends its expertise to offer contract manufacturing and trade services, showcasing a versatile approach to its operations in the healthcare sector.

Products and Services

  • Central Neurological Products: Zhejiang Huahai Pharmaceutical produces medicines aimed at treating central nervous system disorders, contributing to the management and treatment of conditions such as epilepsy, Parkinson's disease, and depression. These products are crucial for alleviating symptoms and improving the quality of life for patients with neurological conditions.
  • Cardiovascular Products: The company offers a variety of cardiovascular drugs, targeting conditions such as hypertension, heart failure, and other heart-related disorders. These products are essential for managing and preventing heart diseases, which are leading causes of death globally.
  • Anti-Viral Products: In response to the escalating need for effective antiviral medications, Zhejiang Huahai Pharmaceutical has developed drugs designed to combat viral infections, reducing the impact of diseases such as influenza, HIV, and hepatitis on affected patients.
  • APIs and Intermediates: Active Pharmaceutical Ingredients (APIs) and intermediates form a crucial part of the company's product line, serving the pharmaceutical industry's need for high-quality components in drug formulation and manufacturing. These products are pivotal for developing a wide range of medications.
  • Packaging Components: Recognizing the importance of reliable and safe pharmaceutical packaging, Zhejiang Huahai offers a range of packaging solutions, including high-density polyethylene bottles and polypropylene caps, designed to protect and preserve the integrity of pharmaceutical products.
  • Contract Manufacturing: Leveraging its comprehensive manufacturing capabilities, the company provides contract manufacturing services, offering clients customized solutions for the production of pharmaceutical products, thereby facilitating the entry of new drugs into the market.
  • Import and Export Trade Services: With a global footprint, Zhejiang Huahai Pharmaceutical engages in the import and export of pharmaceutical products and services, enhancing its international trade operations and allowing for a broader distribution of its offerings.

Contact Information

Address: Xun Bridge, Linhai, China, 317024
Phone: 86 576 8501 0288